Document is current
Any future updates will be listed below
-
Authors
Jenabian, Arash
Ehsanpour, Ali
Mortazavizadeh, Seyed Mohammad Reza
Raafat, Jahangir
Razavi, Mohsen
Khosravi, Adnan
Seifi, Sharareh
Salimi, Babak
Anjidani, Nassim
Kafi, Hamidreza
- License Information
-
More Information
Article History
Received: 11 April 2021
Accepted: 27 June 2022
First Online: 6 July 2022
Declarations
:
: Ethics approval was obtained from the Institutional Research Ethics Committee of Islamic Azad Tehran Medical Sciences University (#IR.IAU.PS.REC.1399.067) and was carried out according to the principles of the Declaration of Helsinki. All participants signed the written informed consent prior to starting the study. The trial was registered at ClinicalTrials.gov (#NCT04460079).
: Consent form is applicable for this study in the Persian language and uploaded as a supplementary file. Also, it can be translated and uploaded in English language later as it is needed.
: Not applicable.
: NA is the head of the medical department of Orchid Pharmed Company, which is in collaboration with CinnaGen Company with respect to conducting clinical trials. HA is head of advisory board in Orchid Pharmed Company. No other potential conflicts of interest relevant to this article were reported.
